Novo Nordisk
NVO
#100
Rank
โ‚น18.312 T
Marketcap
โ‚น4,145
Share price
0.12%
Change (1 day)
-23.37%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): โ‚น2.254 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น51.37 Billion. In 2025 the company made an earning of โ‚น2.009 Trillion, an increase over its 2024 earnings that were of โ‚น1.890 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น2.254 T12.21%
2025 โ‚น2.009 T6.28%
2024 โ‚น1.890 T28.01%
2023 โ‚น1.476 T57.81%
2022 โ‚น935.91 B5.24%
2021 โ‚น889.35 B12.38%
2020 โ‚น791.36 B13.11%
2019 โ‚น699.65 B-3.45%
2018 โ‚น724.64 B1.88%
2017 โ‚น711.25 B4.3%
2016 โ‚น681.90 B10.32%
2015 โ‚น618.10 B7.47%
2014 โ‚น575.16 B3.4%
2013 โ‚น556.24 B19.09%
2012 โ‚น467.09 B15.58%
2011 โ‚น404.13 B16.58%
2010 โ‚น346.66 B25.66%
2009 โ‚น275.88 B10.68%
2008 โ‚น249.27 B55.82%
2007 โ‚น159.97 B7.02%
2006 โ‚น149.48 B19.05%
2005 โ‚น125.56 B10.55%
2004 โ‚น113.57 B
2002 โ‚น76.51 B-14.39%
2001 โ‚น89.37 B-52.82%
2000 โ‚น189.41 B250%
1999 โ‚น54.11 B31.21%
1998 โ‚น41.24 B34.31%
1997 โ‚น30.70 B11.46%
1996 โ‚น27.55 B9.03%
1995 โ‚น25.26 B-3.15%
1994 โ‚น26.08 B-0.67%
1993 โ‚น26.26 B45.38%
1992 โ‚น18.06 B-13.81%
1991 โ‚น20.96 B37.12%
1990 โ‚น15.28 B-0.79%
1989 โ‚น15.40 B26.2%
1988 โ‚น12.20 B24.97%
1987 โ‚น9.76 B-0.9%
1986 โ‚น9.85 B-7.78%
1985 โ‚น10.69 B24.87%
1984 โ‚น8.56 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.015 T-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.983 T 24.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น734.16 B-69.38%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น919.99 B-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA